Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood - Education and Practice 2008;93:19-25; doi:10.1136/adc.2006.107326
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matthews, Y Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthews, Y Y

PHARMACY UPDATE

Drugs used in childhood idiopathic or benign intracranial hypertension

Y Y Matthews

Correspondence to:
Y Y Matthews, North East Wales NHS Trust, Wrexham Maelor Hospital; yim-yee.matthews@new-tr.wales.nhs.uk

The first 150 words of the full text of this article appear below.

Idiopathic intracranial hypertension (IIH) is a rare condition of increased intracranial pressure (ICP) without any identifiable pathology. Despite intervention, the clinical course of IIH is often prolonged and recurring with potentially serious complications of distressing headache and blindness.110 Various therapeutic measures either alone or in combination have been used widely in children with IIH, however, their therapeutic efficacy has not been proven in controlled studies. This article provides a comprehensive review of clinical knowledge in childhood IIH and its various treatment modalities with an emphasis on the drugs used. It also highlights that current management is not evidence based and that well-designed multicentre randomised controlled trials are urgently needed.


*    TERMINOLOGY
 
Idiopathic intracranial hypertension was first described in 189711 as "serous meningitis", followed by various names such as otitic hydrocephalus, toxic hydrocephalus, etc, pseudotumour cerebri,12 and the commonly known benign intracranial hypertension.13 Subsequently, IIH was introduced14 and is now a preferred term . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health